Login
$FBIO
$1.71 -$0.17 (9.04%) Live

Who owns Fortress?

Institutions own
—
of the economics
—
of the votes

Refinery has not recorded this company's share classes yet, so ownership cannot be shown across them.

By class
Class Shares outstanding Held by institutions Votes a share Economics a share
FBIO — — 1 vote 1

How is ownership changing?

Institutions, last 8 quarters

A trend across this company's share classes isn't available yet: each quarter's 13F filings add up shares of classes that differ in economics and votes.

Biggest buyers in Q2 2026
  • Mackenzie Financial Corp NEW +555.7K
  • Gsa Capital Partners LLP +204.3K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Susquehanna International Group, LLP SOLD OUT −210.7K
  • Northern Trust Corp −166.4K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Fortress Biotech, Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2016–FY2025
+947.3%
+29.82% a year
Each share's claim on the business
−90.5%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
$70K vs $188M
over 10 fiscal years
Diluted shares, split-adjusted
2.6M15.4M28.2M2016: 2.7M shares'162017: 2.8M shares'172018: 2.9M shares'182019: 3.6M shares'192020: 4.8M shares'202021: 5.4M shares'212022: 5.9M shares'222023: 8.1M shares'232024: 20.8M shares'242025: 27.9M shares'25
Buybacks Stock-based comp
$0$16.3M$32.6M2016 buybacks: $02016 stock comp: $12.1M'162017 buybacks: $02017 stock comp: $13.4M'172018 buybacks: $02018 stock comp: $15.0M'182019 buybacks: $02019 stock comp: $13.2M'192020 buybacks: $70.0K2020 stock comp: $13.5M'202021 buybacks: $02021 stock comp: $19.5M'212022 buybacks: $02022 stock comp: $23.0M'222023 buybacks: $02023 stock comp: $17.0M'232024 buybacks: $02024 stock comp: $32.6M'242025 buybacks: $02025 stock comp: $28.7M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years50% Under 1 year50%
Quarterly turnover
21.1%
of institutional shares changed hands
Top 10 managers, median time held
2.5 years

Super Investors

Investment managers reporting Fortress on Form 13F
OM
Opaleye Management Inc.
Shares
890.0K
% of company
—
Change vs last qtr
−152.0K (−14.6%)
Held since
Q4 '25
VC
Vanguard Capital Management LLC
Shares
1.0M
% of company
—
Change vs last qtr
+71.2K (+7.4%)
Held since
2023

28 more super investors behind a free account

See every manager holding Fortress Biotech, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting Fortress on Form N-PORT
VT
Position value
$2.14M
% of company
—
% of the fund
0.00%
As of
June 30, 2026
VE
Position value
$856K
% of company
—
% of the fund
0.00%
As of
June 30, 2026

16 more funds behind a free account

See every fund holding Fortress Biotech, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
LA
Lindsay A. Rosenwald, M.D.
5%+ holder13D · 20.7%
Shares
6.9M
% of company
—
Change vs last qtr
—
Held since
—
WM
Weiss Michael S
Insider
Shares
822.3K
% of company
—
Change vs last qtr
—
Held since
—

6 more holders behind a free account

See every insider and 5%+ holder of Fortress Biotech, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support